<DOC>
	<DOCNO>NCT01116557</DOCNO>
	<brief_summary>The purpose study compare efficacy , safety efficiency CARTO® 3 system guide THERMOCOOL® catheter ablation fluoroscopy guide Pulmonary Vein Ablation Catheter® ( PVAC® ) guide ablation treatment paroxysmal atrial fibrillation .</brief_summary>
	<brief_title>Efficacy , Safety Efficiency Study CARTO® 3 System Guided THERMOCOOL® Catheter Ablation Versus Fluoroscopy Guided Ablation With Pulmonary Vein Ablation Catheter® ( PVAC® )</brief_title>
	<detailed_description>This study prospective , multi-center , randomize ( 2:1 ) , control , two-arm , unblinded , clinical study , evaluate efficacy , safety , efficiency CARTO® 3 System-guided RF ablation ( use THERMOCOOL® Catheter LASSO® Circular Mapping Catheter ) compare fluoroscopy-guided RF ablation ( use PVAC® ) . Patients symptomatic PAF meet inclusion criterion consider study participation may enrol exclusion criterion apply . Eligible subject sign study inform consent form randomize one two treatment group : - THERMOCOOL® Group : RF ablation achieve PVI use CARTO® 3 System , THERMOCOOL® Catheter LASSO® Circular Mapping Catheter - PVAC® Group : RF ablation achieve PVI use fluoroscopy PVAC®</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Patients PAF two ( 2 ) symptomatic PAF episode six ( 6 ) month prior randomization , select catheter ablation treatment AF . Additionally patient recurrent AF episodes 30 day sinus rhythm maintain one week follow cardioversion require PVI treatment AF ( support consensus statement2 ) . At least one AF episode document either ECG , TTM , HM telemetry strip . Failure least one AAD PAF [ class I III ] evidence recurrent symptomatic PAF , intolerable side effect due AAD . Signed Patient Informed Consent Form . Age 18 year old . Able willing comply pre followup test requirement . Longstanding persistent atrial fibrillation Patients history atrial flutter require ablation right atrium study procedure Patients sinus rhythm maintain less 1 week electrical cardioversion Previous ablation AF LA size &gt; 55 mm LVEF &lt; 40 % ( ejection fraction ) AF secondary electrolyte imbalance , thyroid disease , reversible noncardiac cause CABG procedure within last six ( 6 ) month Awaiting cardiac transplantation cardiac surgery Documented leave atrial thrombus imaging ( eg , TEE ) Diagnosed atrial myxoma Women pregnant ( history menstrual period pregnancy test history consider unreliable ) breastfeed Acute illness active systemic infection sepsis Unstable angina Uncontrolled heart failure Myocardial infarction within previous two ( 2 ) month History blood clot bleed abnormality Contraindication anticoagulation therapy ( ie . heparin warfarin ) Life expectancy le 12 month Enrollment study evaluate another device drug Presence intramural thrombus , tumor abnormality precludes catheter introduction manipulation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>radiofrequency</keyword>
	<keyword>ablation</keyword>
	<keyword>atrial fibrillation</keyword>
	<keyword>CARTO</keyword>
	<keyword>THERMOCOOL</keyword>
	<keyword>LASSO</keyword>
	<keyword>PVAC</keyword>
</DOC>